Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
6.94
↑ 831% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-0.95
Historical baseline
PeriodValueYoY Change
20256.94+694.9%
2024-1.17-493.3%
2023-0.20+86.6%
2022-1.47+66.2%
2021-4.34+8.4%
2020-4.74-63.1%
2019-2.90-340.2%
2018-0.66-45.8%
2017-0.45+12.4%
2016-0.52-